Advance Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$602K Sell
2,463
-40
-2% -$9.32K 0.02% 96
2025
Q4
$518K Sell
2,503
-38
-1% -$7.51K 0.02% 105
2025
Q3
$471K Buy
2,541
+283
+13% +$48.5K 0.02% 106
2025
Q2
$345K Sell
2,258
-26
-1% -$4K 0.02% 121
2025
Q1
$379K Buy
2,284
+54
+2% +$8.45K 0.02% 109
2024
Q4
$322K Sell
2,230
-41
-2% -$6.35K 0.01% 112
2024
Q3
$368K Sell
2,271
-254
-10% -$40.5K 0.02% 107
2024
Q2
$369K Sell
2,525
-47
-2% -$6.99K 0.02% 102
2024
Q1
$407K Sell
2,572
-156
-6% -$24.8K 0.03% 94
2023
Q4
$428K Sell
2,728
-332
-11% -$50.9K 0.03% 75
2023
Q3
$477K Buy
3,060
+498
+19% +$82.2K 0.04% 68
2023
Q2
$424K Hold
2,562
0.05% 70
2023
Q1
$397K Buy
2,562
+1,330
+108% +$215K 0.07% 64
2022
Q4
$218K Sell
1,232
-104
-8% -$18K 0.03% 98
2022
Q3
$218K Hold
1,336
0.03% 81
2022
Q2
$237K Buy
+1,336
New +$238K 0.03% 74

Other funds holding JNJ

Advance Capital Management's JNJ Position: Q1 2026 in Review

Advance Capital Management reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q1 2026, selling an estimated $9.32K and leaving 2,463 shares worth $602K. The position accounts for 0.02% of the portfolio, ranked #96.

Advance Capital Management first reported a position in JNJ in Q2 2022 and has held it in 16 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Advance Capital Management held 2,463 shares of Johnson & Johnson worth $602K as of Q1 2026.
  • Advance Capital Management sold 40 Johnson & Johnson shares in Q1 2026, an estimated $9.32K.
  • Johnson & Johnson made up 0.02% of Advance Capital Management's portfolio in Q1 2026, its #96 holding.
  • Advance Capital Management first reported a position in Johnson & Johnson in Q2 2022 and has held it in 16 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Advance Capital Management's 13F filing for Q1 2026, filed 29 Apr 2026.